| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.08M | - | |
| Dir | 4.52M | $14.34M | - | |
| CEO | 2.26M | $7.17M | - | |
| Dir | 1.24M | $3.93M | - | |
| Other | 1.11M | $3.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | Borgeson Blake69 | Director | Sell | 8,885 | $7.39 | $65,638.83 | -0.1% | +3.4% | +17.7% | |
| Jun 16, 2023 | Virani Shafique70 | Chief Business Officer | Sale+OE | 60,000 | $9.54 | $572,400.00 | -17.2% | -3.6% | +3.8% | |
| Jun 14, 2023 | Secora Michael74 | Chief Financial Officer | Sale+OE | 50,000 | $10.00 | $500,145.00 | -3.0% | -13.3% | -4.3% | |
| Jun 13, 2023 | Borgeson Blake69 | Director | Sell | 15,485 | $9.98 | $154,506.23 | -0.2% | -16.2% | -6.4% | |
| Jun 7, 2023 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 56,436 | $9.05 | $510,807.88 | -5.8% | -4.1% | -0.7% | |
| Jun 2, 2023 | Virani Shafique70 | Chief Business Officer | Sell | 42,865 | $8.73 | $374,034.45 | -12.3% | +5.7% | +0.6% | |
| May 31, 2023 | Larson Tina Marriott73 | President And COO | Sale+OE | 3,000 | $8.63 | $25,888.20 | -0.7% | -2.7% | +1.1% | |
| May 30, 2023 | Borgeson Blake69 | Director | Sell | 8,885 | $8.79 | $78,133.80 | -0.1% | -2.4% | -2.7% | |
| May 16, 2023 | Borgeson Blake69 | Director | Sell | 8,885 | $5.09 | $45,240.64 | -0.1% | +81.7% | +95.1% | |
| May 3, 2023 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 58,073 | $4.79 | $278,334.90 | -5.7% | +167.7% | +70.3% |